Delivery Order SPE2DB24D2205-SPE2DB25FECRK

Award Date 5/20/25
Potential Completion Date 6/11/25
Potential Value $7.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ENTYVIO 108 MG/0.68 ML PEN 0.68ML, a pharmaceutical product, with a ceiling value of $7,376.46 and a performance period extending through May 28, 2025. The contract is a firm fixed-price, non-set-aside delivery order, indicating open competition. As a prime contractor,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ENTYVIO 108 MG/0.68 ML PEN 0.68ML, a prescription medication, with a ceiling value of $3,688.23 and a performance period through June 4, 2025. This contract is not set aside and is a firm fixed-price arrangement. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,376.46, is for the delivery of ENTYVIO 108 MG/0.68 ML PEN 0.68ML, a specialty pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of April 3, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) that...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $3,688.23 and an ultimate completion date of December 31, 2024. It is for the pharmaceutical product ENTYVIO 108 MG/0.68 ML PEN 0.68ML. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition....
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ENTYVIO 108 MG/0.68 ML PEN 0.68ML, a pharmaceutical product, with a ceiling value of $1,229.41. The contract is a firm fixed price, non-set-aside award with an ultimate completion date of June 16, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ENTYVIO 108 MG/0.68 ML PEN 0.68ML, a specialty medication, with a ceiling value of $7,376.46 and an ultimate completion date of April 28, 2025. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition....
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,458.82, is for the delivery of ENTYVIO 108 MG/0.68 ML PEN 0.68ML, a pharmaceutical product. The contract is a firm fixed price arrangement with a completion date of June 10, 2025. The contract is not a set-aside award, indicating open competition. AmerisourceBergen Drug Corp, the...
This is a delivery order award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of ENTYVIO 108 MG/0.68 ML PEN 0.68ML. The contract has a ceiling value of $14,752.92 and a period of performance through April 8, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ENTYVIO 108 MG/0.68 ML PEN 0.68ML, a pharmaceutical product, with a ceiling value of $2,458.82. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ENTYVIO 108 MG/0.68 ML PEN 0.68ML, a specialty medication, with a total ceiling value of $2,458.82 and a period of performance through March 7, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB25FECRK
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of the medication ENTYVIO 108 MG/0.68 ML PEN 0.68ML, with a ceiling value of $7,376.46 and a period of performance through June 11, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition.

AmerisourceBergen Drug Corp also holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00. This IDC provides a comprehensive global pharmaceutical support vehicle through December 2026, enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard.

Generated 8/24/25, 12:56 AM